Compounds > pyridostigmine bromide
Page last updated: 2024-08-18

pyridostigmine bromide and Obstructive Lung Diseases

pyridostigmine bromide has been researched along with Obstructive Lung Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, CJ; Lane, DJ; Shale, DJ1
Daughaday, CC; Liggett, SB; Senior, RM1

Trials

1 trial(s) available for pyridostigmine bromide and Obstructive Lung Diseases

ArticleYear
Air-flow limitation in myasthenia gravis. The effect of acetylcholinesterase inhibitor therapy on air-flow limitation.
    The American review of respiratory disease, 1983, Volume: 128, Issue:4

    Topics: Airway Resistance; Clinical Trials as Topic; Double-Blind Method; Humans; Ipratropium; Lung Diseases, Obstructive; Middle Aged; Myasthenia Gravis; Pyridostigmine Bromide; Respiratory Function Tests

1983

Other Studies

1 other study(ies) available for pyridostigmine bromide and Obstructive Lung Diseases

ArticleYear
Ipratropium in patients with COPD receiving cholinesterase inhibitors.
    Chest, 1988, Volume: 94, Issue:1

    Topics: Administration, Inhalation; Aged; Atropine Derivatives; Cholinesterase Inhibitors; Humans; Ipratropium; Lung Diseases, Obstructive; Male; Middle Aged; Myasthenia Gravis; Pyridostigmine Bromide

1988